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Introduction 
Approximately 10-22% of patients undergoing total hip arthroplasty (THA) and total knee 
arthroplasty (TKA) are diagnosed with depression.  Pre-operative depression is associated 
with poorer patient reported outcomes, costs and increased complications. Selective 
serotonin-reuptake inhibitors (SSRIs) are first-line treatment for depression due to their 
efficacy and low side effect profile. There are conflicting studies regarding SSRI-related 
bleeding complications. This study compares the rate of bleeding-related complications in 
THA and TKA patients taking SSRI’s to a control group of non-SSRI users. 
Methods 
A retrospective single institution study of 16,407 primary THA and TKA’s from 2008 to 
2018 was performed. Patients with THA for fracture, conversion arthroplasty with existing 
hardware, revision TJA, and uni-compartmental knee arthroplasty.  Patients taking SSRIs 
(2,588) were compared to non-SSRI users (13,819). Patient demographics were reviewed and 
matched at a 3:1 ratio.  Multivariate logistic regression analysis was performed and adjusted 
to control for potential confounders. 
Results 
Patients on SSRI had a significant increase in transfusion, post-operative anemia, irrigation 
and debridement (I&D) and superficial infection. There was a trend towards increased 
hematoma and revision. There was a significantly higher rate of pulmonary embolism for 
SSRI users compared to non-SSRI. Rates of 1-year PJI, hematoma removal or calculated 
blood loss did not differ. 
Discussion 
The rate of bleeding related complications is significantly greater in SSRI users undergoing 
TKA and THA.  Poorer outcomes in depression may be due to the intrinsic nature of the 
disease; however, increased pain due to swelling and wound complications may be due to 
increased rates of bleeding in SSRI users.  
 
